Search | VHL Search Portal

1.

The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 study.

Mhawech-Fauceglia, Paulette; McCarthy, Denis; Tonooka, Akiko; Scambia, Giovanni; Garcia, Yolanda; Dundr, Pavel; Mills, Anne M; Moore, Kathleen; Sanada, Sakiko; Bradford, Leslie; Stella, Giulia Carlo; Bookman, Michael; Sharma, Sudarshan K; Selle, Frederic; Molinero, Luciana; He, Yvette; Khor, Victor; Landen, Charles; Lin, Yvonne G.

Gynecol Oncol ; 186: 17-25, 2024 Mar 29.

Article in English | MEDLINE | ID: mdl-38554625

2.

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.

Pignata, Sandro; Bookman, Michael; Sehouli, Jalid; Miller, Austin; Penson, Richard T; Taskiran, Cagatay; Anderson, Charles; Hietanen, Sakari; Myers, Tashanna; Madry, Radoslaw; Willmott, Lyndsay; Lortholary, Alain; Thomes-Pepin, Jessica; Aghajanian, Carol; McCourt, Carolyn; Stuckey, Ashley; Wu, Xiaohua; Nishio, Shin; Copeland, Larry J; He, Yvette; Molinero, Luciana; Patel, Sheetal; Lin, Yvonne G; Khor, Victor K; Moore, Kathleen N.

Gynecol Oncol ; 177: 20-31, 2023 Oct.

Article in English | MEDLINE | ID: mdl-37625235

3.

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.

Praiss, Aaron M; Miller, Austin; Smith, Judith; Lichtman, Stuart M; Bookman, Michael; Aghajanian, Carol; Sabbatini, Paul; Backes, Floor; Cohn, David E; Argenta, Peter; Friedlander, Michael; Goodheart, Michael J; Mutch, David G; Gershenson, David M; Tewari, Krishnansu S; Wenham, Robert M; Wahner Hendrickson, Andrea E; Lee, Roger B; Gray, Heidi; Secord, Angeles Alvarez; Van Le, Linda; O'Cearbhaill, Roisin E.

Gynecol Oncol ; 174: 213-223, 2023 07.

Article in English | MEDLINE | ID: mdl-37229879

4.

The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.

Sia, Tiffany Y; Tew, William P; Purdy, Christopher; Chi, Dennis S; Menzin, Andrew W; Lovecchio, John L; Bookman, Michael A; Cohn, David E; Teoh, Deanna G; Friedlander, Michael; Bender, David; Mutch, David G; Gershenson, David M; Tewari, Krishnansu S; Wenham, Robert M; Wahner Hendrickson, Andrea E; Lee, Roger B; Gray, Heidi J; Secord, Angeles Alvarez; Van Le, Linda; Lichtman, Stuart M.

Gynecol Oncol ; 173: 130-137, 2023 06.

Article in English | MEDLINE | ID: mdl-37148580

5.

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.

Vergote, Ignace; Gonzalez-Martin, Antonio; Lorusso, Domenica; Gourley, Charlie; Mirza, Mansoor Raza; Kurtz, Jean-Emmanuel; Okamoto, Aikou; Moore, Kathleen; Kridelka, Frédéric; McNeish, Iain; Reuss, Alexander; Votan, Bénédicte; du Bois, Andreas; Mahner, Sven; Ray-Coquard, Isabelle; Kohn, Elise C; Berek, Jonathan S; Tan, David S P; Colombo, Nicoletta; Zang, Rongyu; Concin, Nicole; O'Donnell, Dearbhaile; Rauh-Hain, Alejandro; Herrington, C Simon; Marth, Christian; Poveda, Andres; Fujiwara, Keiichi; Stuart, Gavin C E; Oza, Amit M; Bookman, Michael A.

Lancet Oncol ; 23(8): e374-e384, 2022 08.

Article in English | MEDLINE | ID: mdl-35901833

6.

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.

Coleman, Robert L; Fleming, Gini F; Brady, Mark F; Swisher, Elizabeth M; Steffensen, Karina D; Friedlander, Michael; Okamoto, Aikou; Moore, Kathleen N; Efrat Ben-Baruch, Noa; Werner, Theresa L; Cloven, Noelle G; Oaknin, Ana; DiSilvestro, Paul A; Morgan, Mark A; Nam, Joo-Hyun; Leath, Charles A; Nicum, Shibani; Hagemann, Andrea R; Littell, Ramey D; Cella, David; Baron-Hay, Sally; Garcia-Donas, Jesus; Mizuno, Mika; Bell-McGuinn, Katherine; Sullivan, Danielle M; Bach, Bruce A; Bhattacharya, Sudipta; Ratajczak, Christine K; Ansell, Peter J; Dinh, Minh H; Aghajanian, Carol; Bookman, Michael A.

N Engl J Med ; 381(25): 2403-2415, 2019 12 19.

Article in English | MEDLINE | ID: mdl-31562800

7.

Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study.

Park, Junsik; Kim, Se Ik; Jeong, Soo Young; Kim, Yup; Bookman, Michael A; Kim, Jae-Weon; Kim, Byoung-Gie; Lee, Jung-Yun.

Gynecol Oncol ; 165(1): 97-104, 2022 04.

Article in English | MEDLINE | ID: mdl-35153073

8.

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial.

Aghajanian, Carol; Swisher, Elizabeth M; Okamoto, Aikou; Steffensen, Karina Dahl; Bookman, Michael A; Fleming, Gini F; Friedlander, Michael; Moore, Kathleen N; Tewari, Krishnansu S; O'Malley, David M; Chan, John K; Ratajczak, Christine; Hashiba, Hideyuki; Wu, Meijing; Dinh, Minh H; Coleman, Robert L.

Gynecol Oncol ; 164(2): 278-287, 2022 02.

Article in English | MEDLINE | ID: mdl-34930617

9.

Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.

Swisher, Elizabeth M; Aghajanian, Carol; O'Malley, David M; Fleming, Gini F; Kaufmann, Scott H; Levine, Douglas A; Birrer, Michael J; Moore, Kathleen N; Spirtos, Nick M; Shahin, Mark S; Reid, Thomas J; Friedlander, Michael; Steffensen, Karina Dahl; Okamoto, Aikou; Sehgal, Vasudha; Ansell, Peter J; Dinh, Minh H; Bookman, Michael A; Coleman, Robert L.

Gynecol Oncol ; 164(2): 245-253, 2022 02.

Article in English | MEDLINE | ID: mdl-34906376

10.

Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer: Analysis of the VELIA/GOG-3005 trial.

Aghajanian, Carol; Bookman, Michael A; Fleming, Gini F; Swisher, Elizabeth M; Steffensen, Karina D; Friedlander, Michael; Okamoto, Aikou; Jackson, Camille Gunderson; Sullivan, Danielle; Ratajczak, Christine K; Coleman, Robert L.

Gynecol Oncol ; 162(2): 375-381, 2021 08.

Article in English | MEDLINE | ID: mdl-34112513

11.

Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer.

Fuh, Katherine C; Bookman, Michael A; Liu, Joyce F; Coleman, Robert L; Herzog, Thomas J; Thaker, Premal H; Monk, Bradley J; Anderson, Randy; McIntyre, Gail; Rangwala, Reshma; Moore, Kathleen N.

Gynecol Oncol ; 163(2): 254-261, 2021 11.

Article in English | MEDLINE | ID: mdl-34474927

12.

Can we predict who lives long with ovarian cancer?

Bookman, Michael A.

Cancer ; 125 Suppl 24: 4578-4581, 2019 Dec 15.

Article in English | MEDLINE | ID: mdl-31967684

13.

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.

Fuh, Katherine C; Java, James J; Chan, John K; Kapp, Daniel S; Monk, Bradley J; Burger, Robert A; Young, Robert C; Alberts, David S; McGuire, William P; Markman, Maurie; Bell, Jeffrey; Ozols, Robert F; Armstrong, Deborah K; Aghajanian, Carol; Bookman, Michael A; Mannel, Robert S.

Gynecol Oncol ; 154(2): 420-425, 2019 08.

Article in English | MEDLINE | ID: mdl-31229298

14.

Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.

Gockley, Allison; Melamed, Alexander; Cronin, Angel; Bookman, Michael A; Burger, Robert A; Cristae, Mihaela C; Griggs, Jennifer J; Mantia-Smaldone, Gina; Matulonis, Ursula A; Meyer, Larissa A; Niland, Joyce; O'Malley, David M; Wright, Alexi A.

Am J Obstet Gynecol ; 221(6): 625.e1-625.e14, 2019 12.

Article in English | MEDLINE | ID: mdl-31207237

15.

Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.

Olawaiye, Alexander B; Java, James J; Krivak, Thomas C; Friedlander, Michael; Mutch, David G; Glaser, Gretchen; Geller, Melissa; O'Malley, David M; Wenham, Robert M; Lee, Roger B; Bodurka, Diane C; Herzog, Thomas J; Bookman, Michael A.

Gynecol Oncol ; 151(1): 18-23, 2018 10.

Article in English | MEDLINE | ID: mdl-30135020

16.

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.

Horowitz, Neil S; Larry Maxwell, G; Miller, Austin; Hamilton, Chad A; Rungruang, Bunja; Rodriguez, Noah; Richard, Scott D; Krivak, Thomas C; Fowler, Jeffrey M; Mutch, David G; Van Le, Linda; Lee, Roger B; Argenta, Peter; Bender, David; Tewari, Krishnansu S; Gershenson, David; Java, James J; Bookman, Michael A.

Gynecol Oncol ; 148(1): 49-55, 2018 01.

Article in English | MEDLINE | ID: mdl-29174555

17.

What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.

Rungruang, Bunja J; Miller, Austin; Krivak, Thomas C; Horowitz, Neil S; Rodriguez, Noah; Hamilton, Chad A; Backes, Floor J; Carson, Linda F; Friedlander, Michael; Mutch, David G; Goodheart, Michael J; Tewari, Krishnansu S; Wenham, Robert M; Bookman, Michael A; Maxwell, G Larry; Richard, Scott D.

Cancer ; 123(6): 985-993, 2017 May 15.

Article in English | MEDLINE | ID: mdl-27864921

18.

Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer.

Bookman, Michael A; Tyczynski, Jerzy E; Espirito, Janet L; Wilson, Thomas W; Fernandes, Ancilla W.

Gynecol Oncol ; 146(1): 58-63, 2017 07.

Article in English | MEDLINE | ID: mdl-28454659

19.

Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Moore, Kathleen N; Tritchler, David; Kaufman, Kenneth M; Lankes, Heather; Quinn, Michael C J; Van Le, Linda; Berchuck, Andrew; Backes, Floor J; Tewari, Krishnansu S; Lee, Roger B; Kesterson, Joshua P; Wenham, Robert M; Armstrong, Deborah K; Krivak, Thomas C; Bookman, Michael A; Birrer, Michael J.

Gynecol Oncol ; 147(2): 396-401, 2017 11.

Article in English | MEDLINE | ID: mdl-28935272

20.

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

Oliver, Kate E; Brady, William E; Birrer, Michael; Gershenson, David M; Fleming, Gini; Copeland, Larry J; Tewari, Krishnansu; Argenta, Peter A; Mannel, Robert S; Secord, Angeles Alvarez; Stephan, Jean-Marie; Mutch, David G; Stehman, Frederick B; Muggia, Franco M; Rose, Peter G; Armstrong, Deborah K; Bookman, Michael A; Burger, Robert A; Farley, John H.

Gynecol Oncol ; 147(2): 243-249, 2017 11.

Article in English | MEDLINE | ID: mdl-28807367

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: